Cubist Pushes Fed. Circ. To Revive MRSA Drug Patents
Cubist Pharmaceuticals LLC pushed for a Federal Circuit panel to reinstate four of its five patents on the antibiotic daptomycin Wednesday, saying the trial court incorrectly used Cubist's own patent to...To view the full article, register now.
Already a subscriber? Click here to view full article